Table 3. Therapeutic options for 97 clinically actionable mutations detected in 31 patients.

Therapeutic option, based on mutation	Mutations, n=97, (%)
FDA approved therapy	5 [5]
Clinical trial	46 [47]
Off label	46 [47]

FDA, Federal Drug Administration.